Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: | Completed |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 50 - Any |
Updated: | 5/27/2013 |
Start Date: | February 2011 |
End Date: | November 2012 |
Contact: | James Wartman |
Email: | james.wartman@hoya.com |
Phone: | 909-680-3900 |
The purpose of this multi-center clinical trail is to determine the safety and efficacy of
the iSert 251 for the correction of aphakia.
Inclusion Criteria:
- Have been diagnosed with cataract for which phacoemulsification extraction and
posterior chamber IOL implantation is indicated
- Have clear intraocular media
- Have potential Best Corrected Visual Acuity of 20/40 or better
- Have preoperative Best Spectacle-Corrected visual acuity of 20/40 or worse
Exclusion Criteria:
- Have ocular pathology or abnormalities that do or are expected to reduce best
corrected visual acuity in the operative eye during the study period
- Are monocular
- Have current ocular infection
- Are taking systemic steroids or other anti-metabolites
- Have previous retinal detachment in the operative eye or expect to require retinal
laser treatment during the course of the study
Eligibility criteria not complete. Contact Hoya Surgical Optics, Inc. for more
information.
We found this trial at
5
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials